Ballardini, Maria Pia
Ballardini, Maria Pia
Dipartimento di Scienze mediche
First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era
2023 Urso, Antonio; Cavazzini, Francesco; Ballardini, Maria Pia; Gambara, Silvia; Consolo, Sara; Rigolin, Gian Matteo; Cuneo, Antonio
How to increase the use of screening instruments in oncology settings in Italy
file con accesso da definire2005 Rossi, E; Sabato, S; Ballardini, P; Mangolini, M; Pedrazzi, S; Bernardi, Mp; Benetti, S; Pezzini, O; Indelli, M; Grassi, L
Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study
2024 Rigolin, Gian Matteo; Olimpieri, Pier Paolo; Summa, Valentina; Celant, Simone; Scarfò, Lydia; Ballardini, Maria Pia; Urso, Antonio; Gambara, Silvia; Cavazzini, Francesco; Ghia, Paolo; Cuneo, Antonio; Russo, Pierluigi
Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency
2023 Rigolin, Gian Matteo; Olimpieri, Pier Paolo; Summa, Valentina; Celant, Simone; Scarfò, Lydia; Tognolo, Lucia; Ballardini, Maria Pia; Urso, Antonio; Sessa, Mariarosaria; Gambara, Silvia; Cura, Francesca; Fortini, Monica; Ghia, Paolo; Cuneo, Antonio; Russo, Pierluigi
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| First-Line Treatment of Older Patients with CLL: A New Approach in the Chemo-Free Era | 2023 | Urso, Antonio; Cavazzini, Francesco; Ballardini, Maria Pia; Gambara, Silvia; Consolo, Sara; Rigol...in, Gian Matteo; Cuneo, Antonio | |
| How to increase the use of screening instruments in oncology settings in Italy | 2005 | Rossi, E; Sabato, S; Ballardini, P; Mangolini, M; Pedrazzi, S; Bernardi, Mp; Benetti, S; Pezzini,... O; Indelli, M; Grassi, L | file con accesso da definire |
| Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide study | 2024 | Rigolin, Gian Matteo; Olimpieri, Pier Paolo; Summa, Valentina; Celant, Simone; Scarfò, Lydia; Bal...lardini, Maria Pia; Urso, Antonio; Gambara, Silvia; Cavazzini, Francesco; Ghia, Paolo; Cuneo, Antonio; Russo, Pierluigi | |
| Outcomes in patients with chronic lymphocytic leukemia and TP53 aberration who received first-line ibrutinib: a nationwide registry study from the Italian Medicines Agency | 2023 | Rigolin, Gian Matteo; Olimpieri, Pier Paolo; Summa, Valentina; Celant, Simone; Scarfò, Lydia; Tog...nolo, Lucia; Ballardini, Maria Pia; Urso, Antonio; Sessa, Mariarosaria; Gambara, Silvia; Cura, Francesca; Fortini, Monica; Ghia, Paolo; Cuneo, Antonio; Russo, Pierluigi |